Aurobindo Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sales

12,792.28

11,287.14

15,823.68

13,266.48

12,257.89

Operating profit

1,730.92

1,473.40

4,119.82

2,685.75

2,398.97

Interest

114.98

16.94

28.68

95.58

130.92

Gross profit

2,049.70

2,127.45

4,681.00

2,848.18

2,377.65

EPS (Rs)

21.00

24.83

53.13

31.96

26.11

Other income

433.76

670.99

589.86

258.01

109.60

Stock adjustment

-466.00

45.51

2.99

-229.53

-289.80

Raw material

7,247.69

5,783.93

7,215.73

6,747.55

6,455.30

Power and fuel

-

-

-

-

-

Employee expenses

1,641.88

1,600.04

1,735.43

1,561.47

1,362.77

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

2,637.79

2,384.26

2,749.71

2,501.24

2,330.65

Provisions made

-

-

-

-

-

Depreciation

435.35

415.26

487.99

470.48

413.03

Taxation

383.94

182.77

1,080.10

504.96

434.89

Net profit / loss

1,230.41

1,454.71

3,112.91

1,872.74

1,529.73

Extra ordinary item

-

-74.71

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

58.59

58.59

58.59

58.59

58.59

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

13.53

13.05

26.04

20.24

19.57

GPM (%)

15.50

17.79

28.52

21.06

19.23

NPM (%)

9.30

12.17

18.97

13.85

12.37